Hone Health secured $228 million to advance its longevity platform, including $28 million in equity via Series A financing and $200 million in growth financing from General Catalyst’s Customer Value Fund. The funding positions Hone to expand product and research capabilities tied to aging-related interventions. For the life sciences sector, the round highlights the continued flow of large-scale capital into longevity-focused clinical and data infrastructure efforts, where platform differentiation and evidence generation are increasingly central to fundraising momentum.
Get the Daily Brief